Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 232

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

Open access
Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V., Eidelberg, D.·2008·Neurology

Abstract

Objective: To use 18F-fluorodeoxyglucose (FDG) and PET to investigate changes in regional metabolism associated with mild cognitive impairment (MCI) in Parkinson disease (PD). Cognitive abnormalities are common in PD. However, little is known about the functional abnormalities that underlie the manifestations of MCI in this disorder. Methods: We used FDG PET to measure regional glucose metabolism in patients with PD with multiple-domain MCI (MD-MCI; n = 18), with single-domain MCI (SD-MCI; n = 15), and without MCI (N-MCI; n = 18). These patients were matched for age, education, disease duration, and motor disability. Maps of regional metabolism in the three groups were compared using statistical parametric mapping (SPM). We also computed the expression of a previously validated cognition-related spatial covariance pattern (PDCP) in the patient groups and in an age-matched healthy control cohort (n = 15). PDCP expression was compared across groups using analysis of variance. Results: SPM revealed decreased prefrontal and parietal metabolism (p < 0.001) in MD-MCI relative to N-MCI, as well as an increase in brainstem/cerebellar metabolism (p < 0.001) in this group. In these regions, SD-MCI occupied an intermediate position between the two other groups. PDCP expression was abnormally elevated in the N-, SD-, and MD-MCI groups (p < 0.05), increasing stepwise with worsening cognitive impairment (p < 0.01). Conclusions: Early cognitive decline in Parkinson disease as defined by mild cognitive impairment is associated with discrete regional changes and abnormal metabolic network activity. The quantification of these alterations with 18F-fluorodeoxyglucose PET may allow for the objective assessment of the progression and treatment of this disease manifestation. GLOSSARY: BA = Brodmann area; BNT = Boston Naming Test; CVLT = California Verbal Learning Test; FDG = 18F-fluorodeoxyglucose; FWHM = full width at half maximum; HVOT = Hooper Visual Organization Test; MCI = mild cognitive impairment; MD-MCI = multiple domain MCI; MMSE = Mini-Mental State Examination; PD = Parkinson disease; PDCP = PD-related cognitive pattern; SD-MCI = single domain MCI; SDMT = Symbol Digit Modality Test; SPM = statistical parametric mapping; UPDRS = Unified Parkinson9s Disease Rating Scale; VOI = volume of interest; WCST = Wisconsin Card Sorting Test.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000304050.05332.9c

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 232

Metadata

Authors
Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V., & Eidelberg, D.
Venue
Neurology
Published
2008-04-15
Volume
70
Issue
16_part_2
Pages
1470-1477
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2120571685
Cited by
232
References
3
FWCI
14.21
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. https://app.cochat.ai/papers/10.1212/01.wnl.0000304050.05332.9c
The paper
Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V., & Eidelberg, D. (2008). Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology. https://doi.org/10.1212/01.wnl.0000304050.05332.9c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.